RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+22.15%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.76B
AUM Growth
+$2.76B
(+6.3%)
Cap. Flow
-$23.6M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
29.44%
Holding
155
New
8
Increased
52
Reduced
20
Closed
10
Top Buys
| 1 |
Boston Scientific
BSX
|
$24.2M |
| 2 |
ALLK
Allakos
ALLK
|
$18.2M |
| 3 |
Encompass Health
EHC
|
$17.7M |
| 4 |
Elanco Animal Health
ELAN
|
$13.1M |
| 5 |
Zimmer Biomet
ZBH
|
$8.41M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$26.8M |
| 2 |
AbbVie
ABBV
|
$26M |
| 3 |
Gilead Sciences
GILD
|
$25.9M |
| 4 |
Acadia Healthcare
ACHC
|
$19.5M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$19.4M |
Sector Composition
| 1 | Healthcare | 89.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $157M | 5.67% | 589,098 +21,598 | +4% | +$5.75M |
|
2
Intuitive Surgical
ISRG
$170B
| $81.2M | 2.94% | 141,400 -500 | -0.4% | -$287K |
|
3
Molina Healthcare
MOH
$9.8B
| $81M | 2.93% | 545,000 | – | – |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $79.3M | 2.87% | 645,000 +14,600 | +2% | +$1.8M |
|
|
WCG
5
DELISTED
Wellcare Health Plans, Inc.
WCG
| $75.5M | 2.73% | 235,500 +12,500 | +6% | +$4.01M |
|
6
Madrigal Pharmaceuticals
MDGL
$9.76B
| $73.2M | 2.65% | 342,000 -300 | -0.1% | -$64.2K |
|
|
AMRN
7
Amarin Corp
AMRN
$311M
| $70.4M | 2.55% | 4,325,000 +325,000 | +8% | +$5.29M |
|
|
GWPH
8
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $69.1M | 2.5% | 400,000 -40,000 | -9% | -$6.91M |
|
9
Pacira BioSciences
PCRX
$1.2B
| $63.5M | 2.3% | 1,292,479 +94,479 | +8% | +$4.64M |
|
10
HCA Healthcare
HCA
$94.5B
| $63.3M | 2.29% | 455,000 +25,000 | +6% | +$3.48M |
|
|
11
Encompass Health
EHC
$12.3B
| $52.7M | 1.91% | 676,500 +226,500 | +50% | +$17.7M |
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $50.1M | 1.82% | 310,500 +13,000 | +4% | +$2.1M |
|
13
iRhythm Technologies
IRTC
$5.46B
| $45.4M | 1.65% | 480,000 | – | – |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $41.7M | 1.51% | 300,000 -192,500 | -39% | -$26.8M |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $37.8M | 1.37% | 196,000 +5,500 | +3% | +$1.06M |
|
|
ONC
16
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $37M | 1.34% | 215,000 | – | – |
|
17
Penumbra
PEN
$10.6B
| $35.2M | 1.27% | 235,200 -1,550 | -0.7% | -$232K |
|
|
LOXO
18
DELISTED
Loxo Oncology, Inc
LOXO
| $34.7M | 1.26% | 202,981 -86,919 | -30% | -$14.8M |
|
19
Teleflex
TFX
$5.59B
| $33M | 1.19% | 124,000 +31,500 | +34% | +$8.38M |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $32.3M | 1.17% | 360,400 | – | – |
|
21
Stryker
SYK
$150B
| $31.8M | 1.15% | 179,000 +1,000 | +0.6% | +$178K |
|
|
PRAH
22
DELISTED
PRA Health Sciences, Inc.
PRAH
| $31.8M | 1.15% | 288,247 | – | – |
|
23
Edwards Lifesciences
EW
$47.8B
| $31.3M | 1.13% | 180,000 +15,000 | +9% | +$2.61M |
|
|
24
Boston Scientific
BSX
$156B
| $30.8M | 1.12% | 800,000 +627,500 | +364% | +$24.2M |
|
25
Inogen
INGN
$216M
| $30.8M | 1.11% | 126,000 +7,000 | +6% | +$1.71M |
|